Voclosporin Success

Phase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint Good news posted yesterday on the Lupus Foundation of America website. To see the full article please click here. “(Washington DC – August 15)  Today Aurinia Pharmaceutical Company announced positive top-line results of a Phase IIB clinical study of voclosporin, a potential new therapy option for […]

Survey on Access to Healthcare

EPF launches its survey on Access to Healthcare. This is a project that LUPUS EUROPE has been actively involved in as a participant in the Access to Healthcare work group at EPF. Designed by patients and patient representatives, EPF launches a unique survey on access to healthcare. Share your experience on access and help us […]

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

🌈 The right to health is a basic human right. Everyone must have access to the health services they need when & where they need them without 💶 hardship.

😔 30% of the global population is not able to access essential health services.

#StandWithScience #WorldHealthDay #WHD2026
... See MoreSee Less

🌈 The right to he

🚀 #LupusGPT & #EasyLupus are currently offline as we continue improving them.

🛠️You thought they couldn’t get better? We know they can, & we’re making it happen.

In the meantime, for reliable, multilingual lupus information👉 lupus100.org/

💜Thanks for your support!
... See MoreSee Less

🚀 #LupusGPT & #Ea

🎥 Did you miss our ELM 2026 Recap Webinar?

😃 Watch it now on our YouTube channel!

👉 Our Patient Advisory Network (PAN) members and volunteers share their key takeaways from the European Lupus Meeting 2026.

👉 Doctors and researchers explain, in a clear, short, and patient-friendly way, key messages from their talks.

🎯 Click the link below and discover the latest advances in lupus, explained directly by experts:

www.youtube.com/watch?v=Bw5Iptu-ZNc

More insights from #elm2026 coming soon. Stay tuned!
... See MoreSee Less

🎥 Did you miss ou